Research Article

In silico comparative analysis of HIV protease inhibitors effect on 2019-nCoV coronavirus 3CLpro

Vandna Kumari and Shamsher Singh Kanwar*

Published: 07/03/2020 | Volume 4 - Issue 1 | Pages: 012-014

Abstract

The novel coronavirus 2019-nCoV has become a bane to mankind and spread worldwide and infected many people. Thus, there is an urgent need of a cure for the severe pneumonia disease caused by this virus. In this study, in silico comparative analysis has been done for HIV protease inhibitors on coronavirus 3CLpro protein which has shown the major interactions and common amino acid residues involved in interactions. The amino acid interaction analysis has revealed two amino acids ARG4, LYS5 to be the major amino acids targets among selected ligands. The binding energy analysis has also revealed Cobicistat as one of these best suited ligand for 3CLpro.

Read Full Article HTML DOI: 10.29328/journal.apb.1001011 Cite this Article

References

  1. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020; 19: 149-150. PubMed: https://pubmed.ncbi.nlm.nih.gov/32127666/
  2. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013; 503: 535-538. PubMed: https://pubmed.ncbi.nlm.nih.gov/24172901/
  3. Wang LF, Shi Z, Zhang S, Field H, Daszak P, et al. Review of bats and SARS. Emerg Infect Dis. 2006; 12: 1834-1840. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291347/
  4. Chen Y, Guo D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol Sin. 2016; 31: 3-11. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091378/
  5. Kim UJ, Won EJ, Kee SJ, Jung S, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome. Antivir Ther. 2016; 21: 455-459. PubMed: https://pubmed.ncbi.nlm.nih.gov/26492219
  6. Pang J, Wang  MX, Ang IYH, Tan  SHX, Lewis RF, et al, Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review J Clin Med. 2016; 9: 623. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/
  7. Lv Z, Chu Y, Wang Y. HIV protease inhibitors: a review of molecular selectivity and toxicity. HIV AIDS. 2015; 7: 95–104. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396582/  
  8. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J Comput Chem. 2009; 30: 2785-2791. PubMed: https://pubmed.ncbi.nlm.nih.gov/19399780/